|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 47/48 | (2006.01) |
| A61K 9/08 | (2006.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| A61K 38/21 | (2006.01) | ||
| A61K 47/34 | (2006.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1043025 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00107100.0 |
| Date of filing the European patent application | 2000-04-06 | |
| (97) | Date of publication of the European application | 2000-10-11 |
| (45) | Date of publication and mention of the grant of the patent | 2005-06-01 |
| (46) | Date of publication of the claims translation | 2005-08-25 |
| (30) | Number | Date | Country code |
| 288359 | 1999-04-08 | US |
| (72) |
Rose, Esther Helen, US
Rybak, Mary Ellen, US
|
| (73) |
MERCK SHARP & DOHME CORP.,
126 East Lincoln Avenue, Rahway, New Jersey 07065,
US
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Inkstų ląstelių karcinomos gydymas |
| Renal cell carcinoma treatment |
| Payment date | Validity (years) | Amount | |
| 2016-03-17 | 17 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2017-04-06 |